HealthcareServices

Viral Hepatitis Market Trends and Insights: Global Forecast to 2030

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the viral hepatitis market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Viral Hepatitis Market size between 2026 and 2035?

The viral hepatitis market has experienced consistent expansion in recent years. Its valuation is projected to increase from $16.77 billion in 2025 to $17.37 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 3.6%. Historically, this growth is primarily due to several factors, including enhanced blood screening practices, broader vaccination coverage, the widespread availability of antiviral medications, a rise in disease awareness, and the implementation of public health hepatitis programs.

The viral hepatitis market is projected to experience consistent expansion over the coming years, reaching a valuation of $20.85 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.7%. This growth during the forecast period is fueled by an intensifying focus on hepatitis elimination initiatives, increasing investments in novel antiviral drugs, the broader deployment of point-of-care diagnostics, the rising uptake of combination therapies, and the expansion of global screening programs. Furthermore, significant trends anticipated in the forecast period include the increasing adoption of advanced antiviral therapies, a rising reliance on molecular diagnostic techniques, a growing emphasis on early disease detection, the expansion of vaccination programs, and enhanced monitoring of chronic hepatitis cases.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13028&type=smp

Which Drivers Are Impacting Market Performance In The Viral Hepatitis Market?

The increasing incidence of hepatitis is projected to stimulate the growth of the viral hepatitis market moving forward. Hepatitis refers to an infection of the liver, caused by various infectious viruses and non-infectious agents, which can lead to a range of medical issues. Viral hepatitis, characterized by inflammation and damage to the liver, can be caused by viruses including Hepatitis A, B, C, D, and E. As an illustration, in April 2025, data from the European Centre for Disease Prevention and Control (ECDC), a Sweden-based European Union (EU) health agency, indicated that in 2023, 30 EU/EEA Member States documented 37,766 newly diagnosed cases of hepatitis B virus (HBV) infection, equating to a crude rate of 8.1 cases per 100 000 population. Therefore, the rising prevalence of hepatitis is set to drive the viral hepatitis market.

Which Segments Are Contributing To The Growth Of The Viral Hepatitis Market?

The viral hepatitis market covered in this report is segmented –

1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types

2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis

3) By Treatment: Antiviral Drugs, Surgery, Vaccine, Immune Modulator Drugs, Other Treatments

4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Hepatitis A: Acute Hepatitis A, Chronic Hepatitis A

2) By Hepatitis B: Acute Hepatitis B, Chronic Hepatitis B, Hepatitis B Carrier

3) By Hepatitis C: Acute Hepatitis C, Chronic Hepatitis C

4) By Other Disease Types: Hepatitis D, Hepatitis E

Which Trends Are Shaping Activity Within The Viral Hepatitis Market?

Leading companies in the viral hepatitis market are strategically integrating advanced immunoassay technologies, such as automated, dual-marker immunoassays, to bolster early detection and disease monitoring. These automated, dual-marker immunoassays function as in-vitro diagnostic tests that simultaneously identify both antigen and antibody from a single sample, thereby enabling capabilities like near-real-time assessment of infection status, a compressed diagnostic window, and increased screening throughput. For example, in July 2023, Roche Diagnostics India, an India-based provider specializing in in-vitro diagnostics and laboratory automation solutions, unveiled Elecsys HCV Duo. This dual-antigen and antibody immunoassay is specifically engineered to detect the hepatitis C virus, featuring the concurrent and independent identification of HCV core antigen and anti-HCV antibodies from a single serum or plasma specimen. This innovation facilitates a significantly earlier diagnosis of active HCV infection and is compatible with automated analyzer platforms such as cobas e 402 and e 801. The introduction of Elecsys HCV Duo enhances early detection, accelerates the linkage to care, streamlines diagnostic workflows, and alleviates the burden on healthcare systems.

Who Are The Prominent Global Companies Shaping The Viral Hepatitis Market Landscape?

Major companies operating in the viral hepatitis market are Pfizer Inc., Johnson & Johnson Co, F Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy’s Laboratories, Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd., Wockhardt Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Which Region Currently Holds The Largest Share Of The Viral Hepatitis Market?

North America was the largest region in the viral hepatitis market in 2025. The regions covered in the viral hepatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Viral Hepatitis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13028&type=smp

Browse Through More Reports Similar to the Global Viral Hepatitis Market 2026, By The Business Research Company

Hepatitis C Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Hepatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

Hepatitis Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795